Consun Pharmaceutical Group Limited (HKG:1681)
Hong Kong · Delayed Price · Currency is HKD 15.10
-0.33 (-2.14%)
May 12, 2026, 4:08 PM HKT
HKG:1681 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,078 | 910.46 | 784.53 | 682.91 | 590.17 |
Depreciation & Amortization | 66.59 | 63.99 | 78.09 | 76.36 | 72.99 |
Loss (Gain) From Sale of Assets | 1.93 | 0.35 | 0.85 | 4.12 | 1.99 |
Loss (Gain) From Sale of Investments | -3.47 | 0.09 | -0.23 | - | - |
Loss (Gain) on Equity Investments | 1.6 | 0.07 | - | - | - |
Stock-Based Compensation | - | - | - | -1.78 | 23.41 |
Provision & Write-off of Bad Debts | -1.02 | -8.78 | -12.6 | -32.49 | -18.04 |
Other Operating Activities | -23.85 | -33.07 | -14.33 | 39.93 | -90.34 |
Change in Accounts Receivable | -21.51 | -27.9 | -1.71 | 113.87 | 114.21 |
Change in Inventory | 18.27 | 77.41 | -89.69 | -54.9 | -39.56 |
Change in Accounts Payable | 138.57 | 116.92 | 80.76 | 114.41 | 50.99 |
Change in Unearned Revenue | -1.94 | -4.55 | -0.46 | 2.26 | 1.67 |
Change in Other Net Operating Assets | -41.44 | -8.01 | -6.24 | 3 | 18.04 |
Operating Cash Flow | 1,212 | 1,087 | 818.97 | 947.68 | 725.54 |
Operating Cash Flow Growth | 11.48% | 32.73% | -13.58% | 30.62% | -16.32% |
Capital Expenditures | -68.48 | -109 | -52.56 | -51.59 | -98.25 |
Sale of Property, Plant & Equipment | - | 0.33 | 0.15 | 1.2 | 0.32 |
Sale (Purchase) of Intangibles | -1,018 | - | - | - | - |
Investment in Securities | -1,121 | -143.06 | -248.27 | -365.67 | -230 |
Other Investing Activities | 54.05 | 64.82 | 68.92 | 47.26 | 29.62 |
Investing Cash Flow | -2,153 | -186.91 | -231.77 | -368.8 | -298.31 |
Long-Term Debt Issued | 223.07 | 497.55 | 442.39 | 259.32 | 295.72 |
Long-Term Debt Repaid | -276.38 | -758.2 | -382.93 | -436.67 | -235.81 |
Net Debt Issued (Repaid) | -53.32 | -260.65 | 59.46 | -177.35 | 59.91 |
Issuance of Common Stock | 16.03 | 142.99 | 14.2 | 2.64 | 14.57 |
Repurchase of Common Stock | -168.02 | - | - | -29.07 | -30.15 |
Common Dividends Paid | -498.39 | -680.54 | -326.25 | -127.49 | -198.08 |
Other Financing Activities | -8.04 | 68.94 | -27.51 | -10.93 | -12.91 |
Financing Cash Flow | -711.74 | -729.26 | -280.1 | -342.21 | -166.66 |
Foreign Exchange Rate Adjustments | -20.24 | -11.4 | -9.01 | 17.18 | -4.52 |
Net Cash Flow | -1,673 | 159.42 | 298.09 | 253.85 | 256.05 |
Free Cash Flow | 1,143 | 977.99 | 766.41 | 896.09 | 627.29 |
Free Cash Flow Growth | 16.91% | 27.61% | -14.47% | 42.85% | -23.35% |
Free Cash Flow Margin | 33.46% | 32.96% | 29.59% | 38.30% | 30.68% |
Free Cash Flow Per Share | 1.34 | 1.18 | 0.96 | 1.13 | 0.78 |
Cash Interest Paid | 4.36 | 24.89 | 1.09 | 0.56 | 12.91 |
Cash Income Tax Paid | 34.3 | 37.18 | 20.03 | 13.21 | 134.68 |
Levered Free Cash Flow | -208.28 | 681.72 | 507.99 | 650.74 | 464.15 |
Unlevered Free Cash Flow | -205.55 | 697.28 | 521.28 | 657.57 | 472.21 |
Change in Working Capital | 91.94 | 153.88 | -17.34 | 178.64 | 145.35 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.